Puma Biotechnology（NASDAQ：PBYI）公佈了季度每股收益爲$0.43，遠超分析師共識預期的$0.10，增幅達330%。與去年同期的每股收益$0.31相比增長了38.71%。公司本季度銷售額爲$59.10百萬，超出分析師共識預期的$52.50百萬，增幅爲12.57%。但與去年同期的$72.20百萬相比，銷售額下滑了18.14%。

以上內容來自Benzinga Earnings專欄，原文如下：

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.10 by 330 percent. This is a 38.71 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $59.10 million which beat the analyst consensus estimate of $52.50 million by 12.57 percent. This is a 18.14 percent decrease over sales of $72.20 million the same period last year.